Report
Usama Jiffry
EUR 4.42 For Business Accounts Only

Hemas Holdings PLC - Earnings Review 4QFY2017

HHL has proved to be a consistent counter growing its core business sectors. The healthcare and FMCG sectors have over the recent past experienced growth momentum in its top line. The company has been successful in mitigating the effects of the VAT increases affecting its core businesses.

We believe the current price level of the counter factors in the short term opportunities present for the company. We are also of the view that the

growth momentum from its investments in Bangladesh and locally will accrue over the medium to long term. As such we currently estimate a price target of LKR 125.50 for HHL, and therefore recommend REDUCING holdings in the counter at its current price levels.

Underlying
Hemas Holdings

Provider
Candor
Candor

​Candor Equities Limited is licensed and regulated by the Securities Exchange Commission (SEC) of Sri Lanka and is a Trading Member of the Colombo Stock Exchange (CSE). We assist both local and foreign individual and institutional investors with their listed Equity and Debt trading on the Colombo Stock Exchange.

We are a fully fledged financial services group of companies based in Colombo. The newly branded Candor came into commercial existence in May 2013 with EPIL’s acquisition of Heraymila Group Sri Lanka which was in operation since 2010. Candor’s immediate parent is the Dubai International Financial Centre (DIFC) based Eagle Proprietary Investments Limited (EPIL). Our ultimate parent is the National Industries Group (NIG), one of the largest listed companies on the Kuwait Stock Exchange. Candor’s business domain is strengthened with operating licenses comprising of Stock Broking, Asset Management, Investment Management and Corporate Financing, all vital cogs in Sri Lanka’s service sector driven macro economy.

Analysts
Usama Jiffry

Other Reports on these Companies
Other Reports from Candor

ResearchPool Subscriptions

Get the most out of your insights

Get in touch